[Treatment of Wilson's disease with zinc. 5 cases].
Zinc treatment of Wilson's disease was introduced by Schouwink en 1961 and is still uncommon in France. We evaluated the effectiveness and safety of zinc in 5 patients with Wilson's disease aged from 19 to 40 years. There were three neurological, one hepatic and one asymptomatic cases. Zinc was administered in doses of 120 to 272 mg/day, alone in 3 cases and combined with D-penicillamine in 2 cases. After 1 to 7 years of zinc therapy, our experience is consistent with data from recent literature and provides further evidence of zinc effectiveness. Zinc may be prescribed as first treatment in most patients, including asymptomatic cases. The only exception concerns patients with severe symptoms in whom it is recommended to combine zinc with D-penicillamine during the early phase of treatment for more rapid effectiveness. Because of its safety, zinc is particularly indicated in cases of intolerance to D-penicillamine and trien.
Bona
I
I
Unité Neurométabolique, Hôpital de l'Antiquaille, Lyon.
Broussolle
E
E
Neuschwander
P
P
Confavreux
C
C
Fontanges
T
T
Accominotti
M
M
Chazot
G
G
D000328:Adult; D003300:Copper / Q000097:blood / Q000652:urine; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use*
D003300:Copper; D010396:Penicillamine; D015032:Zinc
Traitement de la maladie de Wilson par le zinc. Cinq cas.